Lavaca Capital’s Colgate-Palmolive CL Stock Holding History

Lavaca Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-40	Closed	-$3K	–	141
2019 Q1	$3K	Hold	40	–	–	﹤0.01%	344
2018 Q4	$2K	Buy	+40	New	+$2.5K	﹤0.01%	328

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Lavaca Capital's CL Position: Q2 2019 in Review

Lavaca Capital sold out of Colgate-Palmolive (CL) in Q2 2019, closing a stake of 40 shares — an estimated $3K sold.

Lavaca Capital first reported a position in CL in Q4 2018 and held it in 2 quarters. The position peaked at $3K in Q1 2019. 1,457 funds tracked by Wall St. Rank hold CL as of Q2 2019.

Lavaca Capital reported no remaining Colgate-Palmolive position as of Q2 2019 after selling out during the quarter.
Lavaca Capital sold 40 Colgate-Palmolive shares in Q2 2019, an estimated $3K.
Lavaca Capital first reported a position in Colgate-Palmolive in Q4 2018 and held it in 2 quarters.
Lavaca Capital's Colgate-Palmolive position peaked at $3K in Q1 2019.
1,457 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2019.

Based on Lavaca Capital's 13F filing for Q2 2019, filed 29 Jul 2019.